Vanguard Group’s Emmaus Life Sciences, Inc. Common Stock EMMA Stock Holding History

Vanguard Group’s Portfolio EMMA Stock Details EMMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,024	Closed	-$16K	–	4188
2019 Q2	$16K	Buy	2,024 +74	+4%	+$549	﹤0.01%	4157
2019 Q1	$16K	Hold	1,950	–	–	﹤0.01%	4103
2018 Q4	$9K	Hold	1,950	–	–	﹤0.01%	4145
2018 Q3	$18K	Buy	1,950 +150	+8%	+$1.49K	﹤0.01%	4155
2018 Q2	$20K	Buy	+1,800	New	+$23.8K	﹤0.01%	4122

Other funds holding EMMA

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Vanguard Group's EMMA Position: Q3 2019 in Review

Vanguard Group sold out of Emmaus Life Sciences, Inc. Common Stock (EMMA) in Q3 2019, closing a stake of 2,024 shares — an estimated $16K sold.

Vanguard Group first reported a position in EMMA in Q2 2018 and held it in 5 quarters. The position peaked at $20K in Q2 2018. 1 fund tracked by Wall St. Rank holds EMMA as of Q3 2019.

Vanguard Group reported no remaining Emmaus Life Sciences, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Vanguard Group sold 2,024 Emmaus Life Sciences, Inc. Common Stock shares in Q3 2019, an estimated $16K.
Vanguard Group first reported a position in Emmaus Life Sciences, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
Vanguard Group's Emmaus Life Sciences, Inc. Common Stock position peaked at $20K in Q2 2018.
1 fund tracked by Wall St. Rank held Emmaus Life Sciences, Inc. Common Stock as of Q3 2019.

Based on Vanguard Group's 13F filing for Q3 2019, filed 14 Nov 2019.